Investigation of 23 Bile Acids in Liver Bile in Benign and Malignant Biliary Stenosis: A Pilot Study

Table 1

Serum bilirubin and C-reactive protein and bile acids in liver bile in benign and malignant biliary stenosis and controls without stenosis.

Parameter	Benign stenosis (); C.I. of mean; Median; IQR	Malignant stenosis (n); C.I. of mean; Median; IQR	Controls without stenosis (); C.I. of mean; Median; IQR
Serum bilirubin (μmol/L)
	44.3	81.3	12.9
	15.0	138.0	15.0
	11.0–49.0	14.5–310.0	11.0–49.0
C-reactive protein (mg/L)
	25.7	28.1	14.2
	2.5	10.0	11.0
	2.0–13.3	5.5–57.5	2.8–55.0
CDCA (μmol/L)
	282.4	11.4	47.4
	43.8	2.9	16.6
	4.5–269.7	0–27.9	0–29.5
GLCA (μmol/L)
	52.6	28.6	81.9
	73.0	12.4	32.1
	27.2–105.8	0–44.7	4.1–260.1
GUDCA (μmol/L)
	4495.4	841.0	1528.9
	192.7	123.7	259.2
	77.4–7507.2	2.6–319.9	38.0–1247.0
GCDCA (μmol/L)
	4021.1	1677.0	1616.3
	6132.0	2642.0	4995.0
	3027.3–10097.8	308.7–5746.8	2404.9–9474.5
GDCA (μmol/L)
	2593.1	840.1	1383.7
	1300.7	381.0	1110.5
	844.1–2995.0	8.9–1497.8	135.9–4421.3
GCA (μmol/L)
	6258.7	2226.7	1302.6
	6929.0	3335.0	5354.0
	2361.8–13126.0	709.1–6549.5	2794.8–7259.0
GHCA (μmol/L)
	14.7	8.2	24.1
	30.1	8.0	16.4
	7.7–36.3	2.7–14.6	10.3–33.8
TLCA (μmol/L)
	32.5	18.4	22.5
	22.3	5.2	19.3
	2.5–56.9	0–16.8	2.1–77.8
TUDCA (μmol/L)
	420.5	61.7	142.6
	46.8	19.2	58.9
	9.5–115.3	0–58.8	9.5–152.8
TCDCA (μmol/L)
	2113.5	736.4	528.2
	1118.5	1734.2	1689.3
	275.2–2301.4	282.3–2319.5	1113.4–3290.7
TDCA (μmol/L)
	772.0	298.2	341.3
	278.8	118.3	377.5
	30.1–1100.8	7.1–321.6	79.8–930.7
TMCA (μmol/L)
	8.8	6.0	6.8
	4.5	3.4	5.9
	0–16.1	0–8.7	0–13.5
THCA (μmol/L)
	15.1	17.4	21.5
	3.8	11.1	12.1
	0.9–14.8	3.1–35.0	4.0–37.2
TCA (μmol/L)
	2821.6	1017.3	643.5
	1634.8	1658.5	1923.1
	366.1–1906.2	652.5–3343.5	1031.2–3048.0
CA (μmol/L)
	259.6	14.6	43.7
	97.8	0	2.6
	5.8–465.9	0–20.4	0–17.7
Total bile acids (mmol/L)
	21.8	14.5	4.8
	26.7	65.8	21.9
	20.5–50.0	43.0–87.2	11.2–33.0